Ritter Pharma (RTTR) Tops Q3 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Ritter Pharma (RTTR) Tops Q3 EPS by 9c

Ritter Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update

November 7, 2016 8:30 AM EST

LOS ANGELES, CA -- (Marketwired) -- 11/07/16 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today reported financial results and a business update for the third quarter ending September 30, 2016.

Recent Highlights

Completed last patient dosing and all monitoring visits in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance on schedule; Topline results of the trial are expected to be announced in the first... More